Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
Parent Node:
expand
Abnormal muscle fiber morphology (HP:0004303)help
..Starting node
..expand
Increased muscle lipid content (HP:0009058)help
Term ID: 9058
Name: Increased muscle lipid content
Synonym: Fat accumulation in muscle fibers; Fat accumulation in muscle fibres; Fat deposits in muscle fibers; Fat deposits in muscle fibres; Increased muscle lipid content; Lipid accumulation in skeletal muscle; Muscle lipidosis; Skeletal muscle lipid accumulation
Definition: An abnormal accumulation of lipids in skeletal muscle.
Comments:
Reference: HP:0009058
Genes and Diseases:
 
       Child Nodes:
........expandIncreased intramyocellular lipid droplets (HP:0012240) help

 Sister Nodes: 
..expandAbnormal muscle fiber protein expression (HP:0030089) help
..expandAbnormal muscle glycogen content (HP:0012269) help
..expandAbnormality of skeletal muscle fiber size (HP:0012084) help
..expandAutophagic vacuoles (HP:0003736) help
..expandCentral core regions in muscle fibers (HP:0030230) help
..expandCentrally nucleated skeletal muscle fibers (HP:0003687) help
..expandDeposits immunoreactive to beta-amyloid protein (HP:0003791) help
..expandHypertrophied muscle fibers (HP:0100293) help
..expandIncreased endomysial connective tissue (HP:0100297) help
..expandInternally nucleated skeletal muscle fibers (HP:0031237) help
..expandMotheaten muscle fibers (HP:0100298) help
..expandMuscle fiber atrophy (HP:0100295) help
..expandMuscle fiber inclusion bodies (HP:0100299) help
..expandMuscle fiber necrosis (HP:0003713) help
..expandMuscle fiber splitting (HP:0003555) help
..expandMyelin-like whorls in vacuolated fibers (HP:0031542) help
..expandNecklace skeletal muscle fibers (HP:0031238) help
..expandPerifascicular muscle fiber atrophy (HP:0100296) help
..expandRagged-red muscle fibers (HP:0003200) help
..expandReduced muscle carnitine level (HP:0030362) help
..expandRimmed vacuoles (HP:0003805) help
..expandRing fibers (HP:0100305) help
..expandType 1 muscle fiber predominance (HP:0003803) help
..expandType 2 muscle fiber predominance (HP:0010602) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0009058HP:0009058Increased muscle lipid content0ABHD5 CL E G H5109921396ORPHA:98907Neutral lipid storage disease with ichthyosis90
HP:0009058HP:0009058Increased muscle lipid content0ACTA1 CL E G H58129ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent96
HP:0009058HP:0009058Increased muscle lipid content0AFG3L2 CL E G H10939315OMIM:614487Spastic ataxia 5, autosomal recessive86
HP:0009058HP:0009058Increased muscle lipid content0CACNA1S CL E G H7791397ORPHA:681Hypokalemic periodic paralysis247
HP:0009058HP:0009058Increased muscle lipid content0CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysis247
HP:0009058HP:0009058Increased muscle lipid content0CHCHD10 CL E G H40091615559ORPHA:457050Autosomal dominant mitochondrial myopathy with exercise intolerance11
HP:0009058HP:0009058Increased muscle lipid content0COL12A1 CL E G H13032188ORPHA:610Bethlem myopathyHP:0040282 - Frequent65
HP:0009058HP:0009058Increased muscle lipid content0COL25A1 CL E G H8457018603ORPHA:91411Congenital ptosis3
HP:0009058HP:0009058Increased muscle lipid content0COL6A1 CL E G H12912211ORPHA:610Bethlem myopathyHP:0040282 - Frequent442
HP:0009058HP:0009058Increased muscle lipid content0COL6A2 CL E G H12922212ORPHA:610Bethlem myopathyHP:0040282 - Frequent478
HP:0009058HP:0009058Increased muscle lipid content0COL6A3 CL E G H12932213ORPHA:610Bethlem myopathyHP:0040282 - Frequent702
HP:0009058HP:0009058Increased muscle lipid content0COQ8A CL E G H5699716812OMIM:612016Coenzyme Q10 deficiency, primary, 4136
HP:0009058HP:0009058Increased muscle lipid content0COX6A2 CL E G H13392279OMIM:619062MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18
HP:0009058HP:0009058Increased muscle lipid content0CPT2 CL E G H13762330ORPHA:228302Carnitine palmitoyl transferase II deficiency, myopathic formHP:0040283 - Occasional101
HP:0009058HP:0009058Increased muscle lipid content0CPT2 CL E G H13762330OMIM:608836Carnitine palmitoyltransferase II deficiency, lethal neonatal.101
HP:0009058HP:0009058Increased muscle lipid content0GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysis
HP:0009058HP:0009058Increased muscle lipid content0ISCU CL E G H2347929882OMIM:255125Myopathy with exercise intolerance, Swedish type19
HP:0009058HP:0009058Increased muscle lipid content0KBTBD13 CL E G H39059437227ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent80
HP:0009058HP:0009058Increased muscle lipid content0KCNE3 CL E G H100086243ORPHA:681Hypokalemic periodic paralysis73
HP:0009058HP:0009058Increased muscle lipid content0KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysis10
HP:0009058HP:0009058Increased muscle lipid content0KLHL41 CL E G H1032416905ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent13
HP:0009058HP:0009058Increased muscle lipid content0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
HP:0009058HP:0009058Increased muscle lipid content0MYH7 CL E G H46257577ORPHA:324604Classic multiminicore myopathyHP:0040282 - Frequent1269
HP:0009058HP:0009058Increased muscle lipid content0MYPN CL E G H8466523246ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent217
HP:0009058HP:0009058Increased muscle lipid content0NDUFA4 CL E G H46977687OMIM:619065MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN214
HP:0009058HP:0009058Increased muscle lipid content0NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0009058HP:0009058Increased muscle lipid content0NEB CL E G H47037720ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent745
HP:0009058HP:0009058Increased muscle lipid content0PNPLA2 CL E G H5710430802OMIM:610717Neutral lipid storage disease with myopathy65
HP:0009058HP:0009058Increased muscle lipid content0PNPLA2 CL E G H5710430802ORPHA:98908Neutral lipid storage myopathy65
HP:0009058HP:0009058Increased muscle lipid content0PNPLA2 CL E G H5710430802ORPHA:565612Triglyceride deposit cardiomyovasculopathyHP:0040281 - Very frequent65
HP:0009058HP:0009058Increased muscle lipid content0SCN4A CL E G H632910591ORPHA:681Hypokalemic periodic paralysis263
HP:0009058HP:0009058Increased muscle lipid content0SDHA CL E G H638910680OMIM:252011Mitochondrial complex II deficiency304
HP:0009058HP:0009058Increased muscle lipid content0SELENON CL E G H5719015999ORPHA:324604Classic multiminicore myopathyHP:0040282 - Frequent144
HP:0009058HP:0009058Increased muscle lipid content0SUCLG1 CL E G H880211449ORPHA:17Fatal infantile lactic acidosis with methylmalonic aciduria60
HP:0009058HP:0009058Increased muscle lipid content0SURF1 CL E G H683411474OMIM:220110Mitochondrial complex IV deficiency73
HP:0009058HP:0009058Increased muscle lipid content0TPM2 CL E G H716912011ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent54
HP:0009058HP:0009058Increased muscle lipid content0TPM3 CL E G H717012012ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent108
HP:0009058HP:0009058Increased muscle lipid content0TRMU CL E G H5568725481ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiencyHP:0040281 - Very frequent101
HP:0009058HP:0009058Increased muscle lipid content0TRNE CL E G H45567479ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiencyHP:0040281 - Very frequent
HP:0009058HP:0009058Increased muscle lipid content0TRNN CL E G H45707493OMIM:220110Mitochondrial complex IV deficiency
HP:0009058HP:0009058Increased muscle lipid content0TRNS1 CL E G H45747497OMIM:220110Mitochondrial complex IV deficiency
HP:0009058HP:0009058Increased muscle lipid content0TTN CL E G H727312403ORPHA:324604Classic multiminicore myopathyHP:0040282 - Frequent7128
HP:0009058HP:0009058Increased muscle lipid content0TTN CL E G H727312403ORPHA:609Tibial muscular dystrophyHP:0040282 - Frequent7128
HP:0009058HP:0009058Increased muscle lipid content0ZFHX4 CL E G H7977630939ORPHA:91411Congenital ptosis
HP:0009058HP:0012240Increased intramyocellular lipid droplets1ABHD5 CL E G H5109921396ORPHA:98907Neutral lipid storage disease with ichthyosisHP:0040282 - Frequent90
HP:0009058HP:0012240Increased intramyocellular lipid droplets1AFG3L2 CL E G H10939315OMIM:614487Spastic ataxia 5, autosomal recessive.86
HP:0009058HP:0012240Increased intramyocellular lipid droplets1CACNA1S CL E G H7791397ORPHA:681Hypokalemic periodic paralysisHP:0040281 - Very frequent247
HP:0009058HP:0012240Increased intramyocellular lipid droplets1CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent247
HP:0009058HP:0012240Increased intramyocellular lipid droplets1CHCHD10 CL E G H40091615559ORPHA:457050Autosomal dominant mitochondrial myopathy with exercise intoleranceHP:0040282 - Frequent11
HP:0009058HP:0012240Increased intramyocellular lipid droplets1COQ8A CL E G H5699716812OMIM:612016Coenzyme Q10 deficiency, primary, 4.136
HP:0009058HP:0012240Increased intramyocellular lipid droplets1COX6A2 CL E G H13392279OMIM:619062MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18
HP:0009058HP:0012240Increased intramyocellular lipid droplets1GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent
HP:0009058HP:0012240Increased intramyocellular lipid droplets1ISCU CL E G H2347929882OMIM:255125Myopathy with exercise intolerance, Swedish type.19
HP:0009058HP:0012240Increased intramyocellular lipid droplets1KCNE3 CL E G H100086243ORPHA:681Hypokalemic periodic paralysisHP:0040281 - Very frequent73
HP:0009058HP:0012240Increased intramyocellular lipid droplets1KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent10
HP:0009058HP:0012240Increased intramyocellular lipid droplets1MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0009058HP:0012240Increased intramyocellular lipid droplets1NDUFA4 CL E G H46977687OMIM:619065MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN214
HP:0009058HP:0012240Increased intramyocellular lipid droplets1NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0009058HP:0012240Increased intramyocellular lipid droplets1PNPLA2 CL E G H5710430802ORPHA:98908Neutral lipid storage myopathyHP:0040281 - Very frequent65
HP:0009058HP:0012240Increased intramyocellular lipid droplets1SCN4A CL E G H632910591ORPHA:681Hypokalemic periodic paralysisHP:0040281 - Very frequent263
HP:0009058HP:0012240Increased intramyocellular lipid droplets1SDHA CL E G H638910680OMIM:252011Mitochondrial complex II deficiency.304
HP:0009058HP:0012240Increased intramyocellular lipid droplets1SUCLG1 CL E G H880211449ORPHA:17Fatal infantile lactic acidosis with methylmalonic aciduriaHP:0040283 - Occasional60
HP:0009058HP:0012240Increased intramyocellular lipid droplets1SURF1 CL E G H683411474OMIM:220110Mitochondrial complex IV deficiency.73
HP:0009058HP:0012240Increased intramyocellular lipid droplets1TRNN CL E G H45707493OMIM:220110Mitochondrial complex IV deficiency.
HP:0009058HP:0012240Increased intramyocellular lipid droplets1TRNS1 CL E G H45747497OMIM:220110Mitochondrial complex IV deficiency.


Genes (39) :ABHD5 ACTA1 AFG3L2 CACNA1S CHCHD10 COL12A1 COL25A1 COL6A1 COL6A2 COL6A3 COQ8A COX6A2 CPT2 GABRA3 ISCU KBTBD13 KCNE3 KCNJ18 KLHL41 MSTO1 MYH7 MYPN NDUFA4 NDUFS4 NEB PNPLA2 SCN4A SDHA SELENON SUCLG1 SURF1 TPM2 TPM3 TRMU TRNE TRNN TRNS1 TTN ZFHX4

Diseases (25) :ORPHA:98907 ORPHA:171439 OMIM:614487 ORPHA:681 ORPHA:79102 ORPHA:457050 ORPHA:610 ORPHA:91411 OMIM:612016 OMIM:619062 ORPHA:228302 OMIM:608836 OMIM:255125 ORPHA:502423 ORPHA:324604 OMIM:619065 OMIM:252010 OMIM:610717 ORPHA:98908 ORPHA:565612 OMIM:252011 ORPHA:17 OMIM:220110 ORPHA:254864 ORPHA:609
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.